Business
How Novus Can Take Advantage of the Proposed Federal Cannabis Research Protections Bill
How Novus Can Take Advantage of the Proposed Federal Cannabis Research Protections Bill.
About this update from Novus Acquisition & Development Corp.
[{"type":"text","content":"[Miami, Florida] — April 22, 2026 —Novus Acquisition & Development Corp. (OTC: NDEV), a national provider of supplemental health insurance plans, operating as Novus Cannabis MedPlan, is a pioneer in offering cannabis coverage for both recreational and medicinal users. The company, which is focused on cannabinoid-based wellness, precision biotech, InsurTech, and health plans, views the introduction of the federal \"Cannabis Research Protections\" bill as a crucial catalyst for sustainable growth. This strategic update to shareholders and the investment community highlights that the landmark legislation—which aims to shield researchers, academic institutions, and clinical participants from federal prosecution—validates and accelerates Novus's long-term business model.For years, the cannabis industry has operated under a \"Catch-22\": federal regulators demanded clinical data to justify policy shifts, yet federal restrictions prevented the very research needed to produce that data. The proposed bill effectively breaks this cycle.A Pivot Toward Institutional-Grade ValidationThe core of the Novus business model has always been the transition from anecdotal consumer health plans to scientifically validated wellness solutions. Until now, major research universities and healthcare providers have remained on the sidelines due to the risk of losing federal funding.\"This bill is the 'Green Light' we have been preparing for since our inception,\" said Frank Labrozzi, CEO of Novus. \"By removing the threat of federal interference, this legislation allows Novus to enter formal partnerships with Tier-1 research institutions. It moves our health plan to a more 'compliant' to 'clinically proven,' which is the single most important factor in unlocking institutional capital and mainstream consumer trust.\"Strategic Impact on the Novus Business ModelThe Novus business model is uniquely positioned to benefit from these protections in three distinct ways:Intellectual Property (IP) Moat Construction: Novus plans to use the robust intellectual property (IP) portfolio generated from these third-party clinical trials to create a competitive \"moat.\" This data, made possible by federal research protections, will accelerate the development of better-targeted health plans and differentiate Novus from mere \"commodity\" cannabis producers.Pathway to In...